AJP - Endocrinology and Metabolism, Vol 271, Issue 2 E215-E222, Copyright © 1996 by American Physiological Society

ARTICLES

Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis

M. C. Moore, L. Rossetti, M. J. Pagliassotti, M. Monahan, C. Venable, D. Neal and A. D. Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232, USA.

The role of the liver nerves in the disposition of peripherally administered glucose was examined in seven hepatic innervated (HI) and nine hepatic denervated (HD) 42-h-fasted conscious dogs. After a 40-min basal period, there was a 4-h experimental period during which the hepatic glucose load was increased twofold via peripheral glucose infusion. Somatostatin was infused to suppress pancreatic endocrine secretion, and insulin and glucagon were infused intraportally to produce a fourfold increase in insulin and a gradual decrease (approximately 25%) in glucagon. The area under the curve of net hepatic glucose uptake (NHGU) during the glucose infusion period totaled 483 +/- 82 and 335 +/- 32 mg/kg in HD and HI, respectively (P < 0.05). The area under the curve of the hepatic fractional extraction of glucose was 27% greater in HD (P < 0.05). Net hepatic lactate output was similar in the two groups, and net hepatic glycogen synthesis was 3.8 +/- 0.8 vs. 2.7 +/- 0.5 mg.kg dog wt-1.min-1 in HD and HI, respectively (P = 0.13). The direct pathway of glycogen synthesis was responsible for 54-58% of net hepatic glycogen synthesis in both HI and HD (n = 6 for both). In summary 1) NHGU in response to peripheral glucose infusion was approximately 44% greater in HD than in HI, 2) net hepatic glycogen synthesis was enhanced by 41% in HD although the probability of this change was 0.13, and 3) the contribution of the direct pathway to glycogen synthesis was the same in HD and HI. These data are consistent with a role for the liver nerves in regulating the magnitude of NHGU in response to glucose administration. They also indicate that the absence of liver nerves may reduce glycogen turnover during glucose infusion.

This article has been cited by other articles:

				C. A. Chu, Y. Fujimoto, K. Igawa, J. Grimsby, J. F. Grippo, M. A. Magnuson, A. D. Cherrington, and M. Shiota Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G627 - G634. [Abstract] [Full Text] [PDF]

				M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF]

				M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853. [Abstract] [Full Text] [PDF]

				F. Zangeneh, R. Basu, P. Shah, P. Arora, M. Camilleri, and R. A. Rizza Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E280 - E286. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266. [Abstract] [Full Text] [PDF]

				M. C. Moore, S. Satake, B. Baranowski, P.-S. Hsieh, D. W. Neal, and A. D. Cherrington Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E286 - E296. [Abstract] [Full Text] [PDF]

				R. Burcelin, A. Da Costa, D. Drucker, and B. Thorens Glucose Competence of the Hepatoportal Vein Sensor Requires the Presence of an Activated Glucagon-Like Peptide-1 Receptor Diabetes, August 1, 2001; 50(8): 1720 - 1728. [Abstract] [Full Text] [PDF]

				K. F. Petersen, D. Laurent, C. Yu, G. W. Cline, and G. I. Shulman Stimulating Effects of Low-Dose Fructose on Insulin-Stimulated Hepatic Glycogen Synthesis in Humans Diabetes, June 1, 2001; 50(6): 1263 - 1268. [Abstract] [Full Text]

				M. C. Moore, P.-S. Hsieh, D. W. Neal, and A. D. Cherrington Nonhepatic response to portal glucose delivery in conscious dogs Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1271 - E1277. [Abstract] [Full Text] [PDF]

				M. C. Moore, P.-S. Hsieh, P. J. Flakoll, D. W. Neal, and A. D. Cherrington Net Hepatic Gluconeogenic Amino Acid Uptake in Response to Peripheral versus Portal Amino Acid Infusion in Conscious Dogs J. Nutr., December 1, 1999; 129(12): 2218 - 2224. [Abstract] [Full Text]

				S. Cardin, M. Emshwiller, P. A. Jackson, W. L. Snead, J. Hastings, D. S. Edgerton, and A. D. Cherrington Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats J Appl Physiol, October 1, 1999; 87(4): 1470 - 1475. [Abstract] [Full Text] [PDF]

				M. C. Moore, P. J. Flakoll, P.-S. Hsieh, M. J. Pagliassotti, D. W. Neal, M. T. Monohan, C. Venable, and A. D. Cherrington Hepatic glucose disposition during concomitant portal glucose and amino acid infusions in the dog Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E893 - E902. [Abstract] [Full Text] [PDF]